Barclays »

Sonoma Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Sonoma Pharmaceuticals (SNOA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Sonoma Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Sonoma Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sonoma Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $564 459 1.23

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Sonoma Pharmaceuticals

Renaissance Technologies
Geode Capital Management
Vanguard Capital Management
McKinley Carter Wealth Services
UBS Group
Global Retirement Partners
Morgan Stanley
Citigroup
Advisor Group Holdings
Barclays
BlackRock
Vanguard Fiduciary Trust
Harbour Investments
Quaker Wealth Management
Danske Bank A/s

View all funds holding Sonoma Pharmaceuticals